Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157

Journal of Physiology Paris

Volumn 94, Issue 2, 2000, Pages 105-110

  Sikiric, Pedrag ^a   Šeparovic, Jadranka ^a   Buljat, Gojko ^a   Anic, Tomislav ^a   Stancic Rokotov, Dinko ^a   Mikus, Darko ^a   Duplancic, Bozidar ^a   Marovic, Anton ^a   Zoricic, Ivan ^a   Prkacin, Ingrid ^a   Lovric Bencic, Martina ^a   Aralica, Gorana ^a   Ziger, Tihomil ^a   Perovic, Darko ^a   Jelovac, Nikola ^a   Dodig, Goran ^a   Rotkvic, Ivo ^a   Mise, Stjepan ^a   Seiwerth, Sven ^a   Turkovic, Branko ^a   Grabarevic, Zeljko ^a   Petek, Marijan ^a   Rucman, Rudolf ^a   more..

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Atropine; Dopaminomimetic s; Doparnine; Gastric lesions; Haloperidol; Haloperidol+reserpine; Omeprazole; Pentadecapeptide BPC 157; Ranitidine; Reserpine

Indexed keywords

ATROPINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALAN YLGLYCYLLEUCYLVALINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; HALOPERIDOL; OMEPRAZOLE; RANITAL; RANITIDINE; RESERPINE; ULTOP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; STOMACH ULCER; ULCER HEALING;

EID: 0034120325     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(00)00147-9     Document Type: Conference Paper

References (34)

1. Bodis B., Karadi O., Nagy L., Dohoczky C., Kolega M., Mozsik G. Direct cellular effects of some mediators, hormones and growth factor-like agents on denervated (isolated) rat gastric mucosal cells. J. Physiol. (Paris). 91:1997;183-187.
2. Carlsson A., Lindquist M., Magnusson T. 3,4-dihydroxyphenylaine and 5-hydroxytryptophan as reserpine antagonists. Nature. 180:1957;1200.
3. Clissold S.P., Campoli-Richards D.M. Omeprazole. An updated review. Drugs. 32:1986;15-47.
4. Hernandez D.E. The role of brain peptides in the pathoghesis of experimental gastric ulcers. Ann. N. Y. Acad. Sci. 597:1990;28-35.
5. Hernandez D.E., Adcock J.W., Orlando R.C., Patrick C.B., Nemeroff R.C., Prange A.J. Prevention of stress induced gastric ulcers by dopamine agonists in the rat. Life Sci. 35:1984;2453-2458.
6. Grabarevic Z., Tisljar M., Artukovic B., Bratulic M., Dzaja P., Seiwerth S., Sikiric P., Peric J., Geres D., Kos J. The influence of BPC 157 on nitric-oxyde agonists and antagonist induced lesions in broiler chicks. J. Physiol. (Paris). 91:1997;139-150.
7. Jelovac N., Sikiric P., Rucman R., Petek M., Perovic D., Konjevoda P., Marovic A., Seiwerth S., Grabarevic Z., Sumajstorcic J., Dodig G. A novel pentadecapeptide BPC 157 blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine. Biol. Psych. 43:1998;511-519.
8. Julien R.M. A Primer of Drug Action. 1997;WH Freeman and Company, New York.
9. Konjevoda P., Nasic M., Curkovic T., Sikiric P., Seiwerth S., Stambuk N. Effects of BPC 157 on the healing of corneal lesions. Ohno S, Aoki K, Usui M, Uchio E. Uveitis Today. 1998;311-314 Elsevier, Amsterdam.
10. Masuda Y., Murai S., Saito H., Abe H., Fujiwara H., Kohori I., Itoh T. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice. Neuropharmacology. 30:1991;35-40.
11. Mozsik G., Abdel-Salam O.M.E., Suto G., Kiraly A., Vincze A., Karadi O. Acetylcholine, pentagastrin, histamine and 2,4-dinitrophenol stimulate the PGI2-induced gastric cytoprotection in ethanol-treated rats. Z. Gastroenterol. 5:1995;301.
12. Paré W., Kluczynski J.M. The effect of new gastric juice peptide BPC on classic stress triad in stress procedure. Exp. Clin. Gastroenterol. 2:1994;234-236.
13. Parmar N.S., Tariq M., Ageel A.M. Effect of bromocriptine, a dopamine receptor agonist, on the experimentally induced gastric ulcers in albino rats. Life Sci. 35:1984;2035-2040.
14. Sandor Z., Vincze A., Szabo S. The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury. FASEB J. 10:1996;171.
15. Sandor Z., Vincze A., Jadus M.R., Dohocky C., Erceg D., Brajsa K., Kolega M., Szabo S. The protective effect of newly isolated peptide PL-10 in the iodoacetamide colitis model in rats. Gastroenterology. 112:1997;400.
16. Seiwerth S., Sikiric P., Grabarevic Z., Zoricic I., Hanzevacki M., Ljubanovic D., Coric V., Konjevoda P., Petek M., Rucman R., Turkovic B., Perovic D., Mikus D., Jadrijevic S., Medvidovic M., Tadic T., Romac B., Kos J., Peric J., Kolega Z. BPC 157 effect on healing. J. Physiol. (Paris). 91:1997;173-178.
17. Sikiric P., Geber J., Ivanovic D., Suchanek E., Gjuris V., Tucan-Foretic M., Mise S., Cvitanovic B., Rotkvic I. Dopamine antagonists induce gastric lesions in rats. Eur. J. Pharmacol. 131:1986;105-109.
18. Sikiric P., Rotkvic I., Mise S., Petek M., Rucman R., Seiwerth S., Zjacic-Rotkvic V., Duvnjak M., Jagic V., Suchanek E., Grabarevic Z., Anic T., Brkic T., Djermanovic T., Dodig M., Marovic A., Hernandez D. Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. Dig. Dis. Sci. 36:1991;905-910.
19. Sikiric P., Petek M., Rucman R., Seiwerth S., Grabarevic Z., Rotkvic I., Turkovic B., Jagic V., Mildner B., Duvnjak M., Lang N. A new gastric juice peptide BPC - an overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects. J. Physiol. (Paris). 87:1993;313-327.
20. 4 application, A comparative study with dopamine agonists and somatostatin. Life Sci. 53:1993;PL291-PL296.
21. 2 receptor antagonists dopamine promoters and gut peptides. Life Sci. 54:1994;PL63-PL68.
22. Sikiric P., Rotkvic I., Mise S., Seiwerth S., Grabarevic Z., Petek M., Rucman R., Zjacic-Rotkvic V., Duvnjak M., Jagic V., Suchanek E., Marovic A., Banic M., Brkic T., Hanzevacki M., Separovic J., Djacic S., Simicevic V. Dopamine agents efficacy in peptic ulcer healing and relapse prevention - a further indication for importance of stomach dopamine in the stress organoprotection concept. Szabo S, Taché Y, Glavin G. Neuroendocrinology of Gastrointestinal Ulceration, Hans Selye Symposia on Neuroendocrinology and Stress. vol. 2:1995;221-230 Plenum Publishing Corporation, New York.
23. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Jurina J., Konjevoda P., Hanzevacki M., Ljubanovic D., Separovic J., Gjurasin M., Bratulic M., Artukovic B., Jelovac N., Buljat G. Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats. Dig. Dis. Sci. 41:1996;1518-1526.
24. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Gjurasin M., Konjevoda P., Separovic J., Ljubanovic D., Artukovic B., Bratulic M., Tisljar M., Jurina L., Buljat G., Miklic P., Marovic A. The beneficial effect of a novel pentadecapeptiide BPC 157 on gastric lesions induced by restraint stress ethanol indomethacin and capsaicin neurotoxicity. Dig. Dis. Sci. 41:1996;1604-1614.
25. 2 blockers and sucralfate on new vessels and new granulation tissue formation. Gastroenterology. 112:1997;291.
26. Sikiric P., Mazul B., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Jurina Lj., Konjevoda P., Hanzevacki M., Gjurasin M., Separovic J., Ljubanovic D., Artukovic M., Bratulic M., Tisljar M., Miklic P., Sumajstorcic J. Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Dig. Dis. Sci. 42:1997;661-671.
27. Sikiric P., Mikus D., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Peric J., Konjevoda P., Perovic D., Jurina L., Hanzevacki M., Separovic J., Gjurasin M., Jadrijevic S., Jelovac N., Miklic P., Buljat G., Marovic A. Pentadecapeptide BPC 157 cimetidine ranitidine bromocriptine and atropine effect in cysteamine lesions in totally gastrectomized rats. A model study for cytoprotective studies. Dig. Dis. Sci. 42:1997;1029-1037.
28. G-nitro-L-arginine methylester and L-arginine effect on stomach mucosal integrity and blood pressure. Eur. J. Pharmacol. 332:1997;23-33.
29. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Perovic D., Simicevic V., Hanzevacki M., Ljubanovic D., Artukovic M., Bratulic M., Tisljar M., Rekic B., Gjurasin M., Miklic P., Buljat G. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agents-induced gastrointestinal lesions and adjuvant arthritis in rats. J. Physiol. (Paris). 91:1997;113-122.
30. Szabo S., Neumeyer J.L. Dopamine agonists and antagonists in duodenal ulcer disease. Kaiser C, Kebabian W. ACS Symposium Series 224. 1983;175-196 American Chemical Society Publications, Washington.
31. Veljaca M., Pllana R., Lesch C.A., Sanchez B., Chan K., Guglietta A. Protective effect of BPC 157 on a rat model of colitis. Gastroenterology. 106:1994;789.
32. Veljaca M., Lech C.A., Pllana R., Sanchez B., Chan K., Guglietta A. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J., Pharmacol. Exp. Ther. 272:1994;417-422.
33. Veljaca M., Chan K., Guglietta A. Digestion of h-EGF h-TGF alfa and BPC 15 in human gastric juice. Gastroenterology. 108:1995;761.
34. Veljaca M., Lesch C.A., Sanchez B., Low J., Guglietta A. Protection of BPC-15 on TNBS-induced colitis in rats: possible mechanisms of action. Gastroenterology. 108:1995;936.